Exclusive Interview with PharmaCann CEO Brett Novey PharmaCann CEO Brett Novey last spoke to New Cannabis Ventures in August 2021. During that conversation, he outlined the private cannabis company’s...

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...

Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc. Four New Directors Join Cronos Group Board Jerry Barbato Appointed Chief Financial Officer of Cronos Group;...

This is a copy of the December 9th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, As we head into the final weeks...

Cronos Group Inc. Announces C$2.4 Billion Strategic Investment from Altria Group, Inc. TORONTO, Dec. 7, 2018 /PRNewswire/ – Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that...

Cronos Group Confirms Discussions Regarding Potential Investment by Altria Group TORONTO, Dec. 3, 2018 /CNW/ – Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today...

Aphria Responds to Media Reports Re: Potential Investment LEAMINGTON, ON, Oct. 10, 2018 /CNW/ – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH or USOTCQB: APHQF) today responded to...